Rolled oral thin films having a high level of active-ingredient loading
US-2024156727-A1 · May 16, 2024 · US
US2016008293A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2016008293-A1 |
| Application number | US-201414769754-A |
| Country | US |
| Kind code | A1 |
| Filing date | Mar 12, 2014 |
| Priority date | Mar 15, 2013 |
| Publication date | Jan 14, 2016 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Disclosed is a dissolvable, gel-forming film, and methods for its use, comprising a water-soluble cellulose ether, a hydrophilic rheological modifying agent, and an active proteolytic enzyme or other drug substance. The gel-forming film has a water content of less than 15% w/w and is capable of forming a hydrogel when contacted with water or other aqueous medium. The disclosed films achieve delivery of stable proteolytic enzymes to the desired site of action in a manner that provides uniform delivery of the enzymes.
Opening claim text (preview).
1 . A dissolvable, gel-forming film comprising: (a) a water-soluble cellulose ether; (b) a hydrophilic rheological modifying agent; and (c) a proteolytic enzyme, wherein the dissolvable, gel-forming film has a water content of less than 15% w/w, and the dissolvable, gel-forming film is capable of forming a hydrogel when contacted with water or other aqueous medium. 2 . The dissolvable, gel-forming film of claim 1 , wherein the proteolytic enzyme is in crystalline form. 3 . The dissolvable, gel-forming film of any of claims 1 - 2 , wherein the hydrogel that is formed has a viscosity of 1,000 to 100,000 cps, as measured using a Brookfield RV Model Viscometer using small sample adapter with spindle #SC4-14 and chamber #SC4-6R, at 10 rpm at room temperature, reading taken at 1 minute. 4 . The dissolvable, gel-forming film of any of claims 1 - 3 , wherein the proteolytic enzyme is themolysin, collagenase, or papain. 5 . The dissolvable, gel-forming film of claim 4 , wherein the proteolytic enzyme is thermolysin. 6 . The dissolvable, gel-forming film of any of claims 1 - 5 , wherein the thickness of the film ranges from 10 to 1000 μm. 7 . The dissolvable, gel-forming film of any of claims 1 - 6 , wherein the film is capable of dissolving in water at a rate from 100 to 0.1 mg/min. 8 . The dissolvable, gel-forming film of claim 7 , wherein the film is capable of dissolving in water at a rate from 0.5-10 mg/min. 9 . The dissolvable, gel-forming film of any of claims 1 - 8 , wherein the weight percent of the proteolytic enzyme is not less than 0.1% of the dry weight of the film and does not decrease by more than 10% when stored at room temperature for 24 months. 10 . The dissolvable, gel-forming film of any one of claims 1 - 9 , wherein the water-soluble cellulose ether is a hydroxyalkyl cellulose ether. 11 . The dissolvable, gel-forming film of claim 10 , wherein the hydroxyalkyl cellulose ether is hydroxyethylcellulose, hydroxypropylcellulose, or hydroxypropylmethylcellulose, or any combination thereof. 12 . The dissolvable, gel-forming film of any one of claims 1 - 11 , comprising 50 to 70% w/w or 55 to 65% w/w of the water-soluble cellulose ether or combinations thereof. 13 . The dissolvable, gel-forming film of any one of claims 1 - 12 , comprising 25 to 35% w/w of hydroxyethylcellulose and 25 to 35% w/w of hydroxypropylmethyl cellulose. 14 . The dissolvable, gel-forming film of any one of claims 1 - 13 , comprising 15 to 25% w/w of the hydrophilic rheological modifying agent. 15 . The dissolvable, gel-forming film of claim 14 , wherein the hydrophilic rheological modifying agent is a polyol. 16 . The dissolvable, gel-forming film of claim 15 , wherein the polyol is polyethylene glycol. 17 . The dissolvable, gel-forming film of claim 16 , wherein the polyethylene glycol is PEG-400. 18 . The dissolvable, gel-forming film of any one of claims 1 - 17 , comprising 5 to 15% w/w of the proteolytic enzyme. 19 . The dissolvable, gel-forming film of any one of claims 1 - 18 , wherein the hydrogel further comprises a metal salt. 20 . The dissolvable, gel-forming film of claim 19 , wherein the metal salt is sodium chloride or calcium chloride or mixtures thereof. 21 . The dissolvable, gel-forming film of any one of claims 1 - 20 , wherein the hydrogel further comprises a preservative. 22 . The dissolvable, gel-forming film of claim 21 , wherein the preservative is methylparaben, propylparaben, or phenoxyethanol, or mixtures thereof. 23 . The dissolvable, gel-forming film of any one of claims 1 - 22 , wherein the film is produced by: (a) obtaining a first mixture comprising 3 to 7% w/w of the cellulose ether or combinations thereof, 1 to 3% w/w of the hydrophilic rheological modifying agent, and Tris Buffer (10 mM, pH=7.5); (b) obtaining a second mixture comprising a proteolytic enzyme, a metal salt, and Tris Buffer (10 mM, pH=7.5); (c) mixing the first and second mixtures together to obtain a hydrogel; and (d) drying the hydrogel from step (c) to obtain the dissolvable, gel-forming film. 24 . The dissolvable, gel-forming film of claim 23 , wherein the proteolytic enzyme is themolysin, collagenase, or papain. 25 . The dissolvable, gel-forming film of claim 24 , wherein the proteolytic enzyme is thermolysin. 26 . A method of debriding a wound comprising topically applying the dissolvable, gel-forming film from any one of claims 1 - 25 to a wound in need of debridement. 27 . The method of claim 26 , wherein the wound is a chronic wound. 28 . The method of claim 27 , wherein the chronic wound is a diabetic foot ulcer, a venous leg ulcer, an arterial leg ulcer, a decubitus ulcer, a stasis ulcer, a dermal ulcer, a burn, or a pressure ulcer. 29 . The method of any one of claims 26 - 28 , wherein the wound includes necrotic tissue. 30 . The method of claim 29 , wherein the necrotic tissue is an eschar. 31 . The method of any one of claims 26 - 30 , wherein an aqueous medium is applied to the wound before the dissolvable, gel-forming film is applied to the wound or wherein an aqueous medium is applied to the dissolvable, gel-forming film after said film is applied to the wound. 32 . The method of claim 31 , wherein the aqueous medium is a saline solution. 33 . The method of any one of claims 26 - 32 , wherein a bandage, wound dressing, or gauze is applied onto the dissolvable, gel-forming film after said film is applied to the wound.
for treating wounds, ulcers, burns, scars, keloids, or the like · CPC title
containing enzymes · CPC title
Drug-containing films, membranes or sheets (A61K9/0041, A61K9/0043, A61K9/006, A61K9/0063 take precedence) · CPC title
Liquid-swellable gel-forming materials, e.g. super-absorbents · CPC title
Thermolysin (3.4.24.27) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.